Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Great RNS, Posted previously about the expected agreement with China, given Allan Symm's previous dealings with them.Still more to come in my opinion, with companion diagnostics, licensing agreements, etcBut the real turning point will be the RNS that tells us about CE and / or 501(k) approval.Neil
Interesting 5 million *sell* after the bell.
5 million shares equates to just short of 2%.
As the reporting threshold is 1%,
if the seller is any of the "significant shareholders" then this will definitely be a TR1 on Wed/Thur
If not, then the seller will surely be out or very nearly by now, as much more would have been in TR1 territory if they have any more.
London South East showing 89 trades today, with a volume of 16,284,649
London Stock Exchange official figures are 94 trades with a volume of 17,475,797
So a discrepancy of 5 trades, and shares traded of 1,191,148
Be interesting to see what the SP does in the morning.
Neil
Looks like a short closing @ 1,293,750 as there are 3 trades matching with exactly the same time stamp.
Also looks like there could possibly be a 200,000 in there too with same time, but one more 200k to come to match up, unless it will be put through late, or a mix of smaller trades to disguise.
Lot more activity than normal today. Wonder if news in the pipeline?
Widglide, appreciate you are still angry about PSL/BOU and the way we were let down. I still maintain my opinion that this is going places, and to back up my theory,
one of the bigger buys was mine (again) as i am slowly building up to a sizeable holding.
But as i always say, only my opinion, and not advice.
Neil
The money raised on the original IPO and placing gave us funding through to end of 2022.
However, don't forget the following income streams:
1. Potential payment for production of antibodies and reagents plus further royalties for sales and services with ICCAMT & ILT on completion of the MOU through to contract.
2. Up to £1million in development fees with SGSC
3. Potential royalties of up to £5million from commerciaiization of AZD1656
1. Any other licensing deals that may be being secured.
So pretty well funded for the foreseeable future.
Neil
That trade was a transfer between 2 parties, but made by the same investment advisor, who acted on behalf of both parties (as buyer from party No1 and seller to party No1)
The trade was not made on the London Stock Exchange, but on a different venue. In this case, it was ECHO.
It was done as a P-ACTX trade which is an agency cross trade.
What it tells us is that the advisor knew someone who owns a lot of shares (institutional?) wanted a sell, but he / she also had a client wanting to take the lot in one go!
Someone appears to be building up their holding
Neil
To all the long term / old BOU / PSL holders, and the newer faces:
I hope you all have a Very Happy Christmas and a Healthy and prosperous New Year, and that our time will come.
There is still much news to follow, and i am confident this will turn out well.
Wideglide; I know that you are feeling let down, and i especially wanted to say that i hope you will see better times coming with this.
When all seemed lost last year, i was confident that we would relist when we were suspended. After the initial red herring with Coeur, I was confident that we would be in the Bio sector. I was confident that Allan Syms would feature highly in the new company. I mentioned that i expected agreements on licensing deals, and that we would enter companion drug deals, and an interest in China.
I am also confident that we are going to make it big. So confident, that despite being well down on my PSL / BOU investment, i have been steadily buying a sizeable part of this company, but that is not to be taken as advice....only what i believe. As i have said previously, the Bio Sector takes time, (but it won't be as long as the timescales some have mentioned) and when all is commercialised, and we have our approval(s) i expect to see a take over at a point in the future. As i said a while back, i am not in this to make a few thousand quid - i am expecting a sizeable return.
All the best everyone, and keep safe.
Neil
Unfortunately, i don't think that is the case.
YORKSHIRE SEEDCORN FUND was a division of Finance Yorkshire, (later Enterprise Ventures who were acquired by MERCIA)
It looks like all that has happened is they have reduced their original holding from 24,437,410 (9.37%) to 23,437,410 which is just below the 9% mark. Because any holding above 5% is reportable, at 15 increments,they have now dropped to a point where a report was required.
Neil
Personally don't think there is any issue with the subject of China's dealings.
The antigen & reagents are currently being manufactured for us by Fairjourney Bio, and China will pay for the use of them in the development of the tests in their country. The development of this, which will be funded by our new partners in this agreement (when it is contractually agreed)
So, yet another income stream for us.
As well as this, we will receive royalties resulting from any sales on future goods and services to China.
Yet another income stream.
China has the worlds biggest problem with lung cancer, and getting our product in there will be a massive coup.
Allan Syms has previously held high level dialogue with the Chinese Minister for Health with his previous dealings with China, so all good in my opinion.
I previously posted (06/09/21) about news i expected regarding antigen/reagent manufacture, companion diagnostic agreements, and further back (09/05/21) about Allan's dealings with China, and my suspicion that we would be entering into an agreement with China.
Well so far, everything seems to be going to plan.
All we need now is news on CE/FDA approval process.
P.S. LB - magnificent work on our other mutual share. Don't post on there because of the bickering, but your input is very highly appreciated.
Neil
Morpheous123
Do not take anything i say as advice.
However, you may find a look back at my previous posts (they go back a long way) a help in seeing the progress and direction of CIZ
My own holding is increasing significantly.
Expect more news shortly,
but do your own research. i am just an investor.
Neil
Wideglide,
You are concentrating on one aspect of this company - the lung cancer.
Couple of things i would like to mention:
Galleri cannot detect 50 cancers in one go. Seperate tests will need to be conducted, and targeted to the particular type of cancer. As an example, there could be 50 cancers, but each one may have 15 types.
Again i would highlight, Galleri is aimed at a specific group of high risk individuals, within the age group of 50 -77 years old.
Our test is aimed at everyone., and at a much earlier stage.
The other point i would like to make is that we aren't a one trick pony. We now have the companion drug with SGS with a revenue of 1million
We are looking at other drugs which SGS has asked us to be involved in a closer relationship with them, backed by Astra Zeneca.
We are looking at drugs in the future that are treating auto-immunity disease.
We are going to be a multi diagnostic company before long.
As always, do not use my opinions/research as your basis for investment, but do your own due diligence.
I have made no secret that i believe in this company. They are advancing at a rapid pace.
To that effect, i will advise that i have upped my holding yet again this morning.
Neil
We have discussed this test previously.
Not as effective as our test.
Not as early as our test.
Only detects larger molecules in the DNA which means the cancer is already at a more advanced stage than our test.
Primarily used as a screening.
Primarily used for those already at a heightened risk.
Primarily used in over 50 age group.
Our test is much better.
Wait for the next news on trials.
Neil
Cymru229,
I did wince a little when i noted last night you mentioned that you were looking to top up this morning.
However, this is great news, but not the big one yet, so there will still be an opportunity in my opinion.
There is more to come.
As always, only my own opinion.
Neil
Finally! the trade of 200,000 was my buy.
It has taken 2 full days to fill.
The original order was for 400,000, but didn't fill. So i offered more than the ask.
Still it didn't get filled.
Eventually had to drop the amount to 200,000, and its taken all day to complete.
Looks like there is a shortage of shares up for grabs.
Neil